SITATREND TRIO
- Rapid reduction in CVD risk.
- Significant HbA1c reduction of 3 month of treatment.
- Metform is in extended release form.
SITATREND TRIO
CILIHART T
- Widens and relaxes the blood vessels which lowers B.P.2
BIOTELM -40 AM
- Significantly lowering of BP at 4 weeks in all age groups and co-morbid hypertensive patients’.
- Preferred combination for Asian diabetic hypertensive with exaggerated early morning blood pressure surge(EMBS).
Â
Â